Literature DB >> 21527417

Relapsing migratory idiopathic orbital inflammation: six new cases and review of the literature.

Noa Avni-Zauberman1, Devjyoti Tripathy, Nachum Rosen, Guy J Ben Simon.   

Abstract

AIMS: To present a case series of relapsing migratory idiopathic orbital inflammation. PATIENTS AND METHODS: Case series and review of the literature. The medical records of six patients with recurrent orbital myositis or idiopathic inflammation at different sites treated at the Goldschleger Eye Institute between April 2006 and December 2009 were collected and analysed; one patient treated at the orbital service in Priyamvada Birla Aravind Eye Hospital, Kolkata, India, was also included (June 2008 to August 2010). Orbital biopsy was performed in patients who failed to respond to steroids treatment.
RESULTS: A total of six patients with recurrent episodes of orbital myositis or inflammation were identified. Four patients had orbital myositis of one extraocular muscle at the initial episode and recurrent myositis of a different extraocular muscle on the contralateral orbit. One patient had recurrent myositis of a different extraocular muscle on the same orbit. Two patients had a third episode of recurrence on a different site, that is, an extraocular muscle or an eyelid. One patient had eyelid and soft tissue involvement on one orbit and recurrence of orbital myositis on the contralateral eyelid. Histological findings in the latter case showed small perivascular lymphocytic aggregates and scattered histiocytes. The mean time for recurrence was 7.2 months. All patients were treated successfully with oral steroids and/or intralesional triamcinolone injection.
CONCLUSIONS: Idiopathic orbital inflammation or orbital myositis can recur on a different extraocular muscle and on the contralateral orbit. These cases can be successfully treated with orally administered or intralesionally injected steroids.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21527417     DOI: 10.1136/bjo.2010.191866

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  9 in total

Review 1.  "Orbiting around" the orbital myositis: clinical features, differential diagnosis and therapy.

Authors:  F Montagnese; S Wenninger; B Schoser
Journal:  J Neurol       Date:  2015-10-17       Impact factor: 4.849

Review 2.  Idiopathic Orbital Myositis Revisited.

Authors:  Ilse Mombaerts; Alan A McNab
Journal:  Curr Rheumatol Rep       Date:  2022-02-09       Impact factor: 4.592

3.  Orbital myositis as an initial manifestation of Behcet's disease.

Authors:  Shinya Abe; Tatsuya Yunoki; Atsushi Hayashi
Journal:  Am J Ophthalmol Case Rep       Date:  2022-06-25

4.  Clinical heterogeneity between two subgroups of patients with idiopathic orbital inflammation.

Authors:  Toshinobu Kubota; Akari Iwakoshi
Journal:  BMJ Open Ophthalmol       Date:  2022-06

Review 5.  Ocular myositis.

Authors:  Clare L Fraser; Simon E Skalicky; Avinash Gurbaxani; Peter McCluskey
Journal:  Curr Allergy Asthma Rep       Date:  2013-06       Impact factor: 4.806

6.  Decreased CD3-CD16+CD56+ natural killer cell counts in children with orbital myositis: a clue to disease activity.

Authors:  Melissa R Briones; Gabrielle A Morgan; Maria C Amoruso; Bahram Rahmani; Maura E Ryan; Lauren M Pachman
Journal:  RMD Open       Date:  2017-07-11

7.  Clinical Features of Ocular Motility in Idiopathic Orbital Myositis.

Authors:  Min Seok Kang; Hee Kyung Yang; Namju Kim; Jeong-Min Hwang
Journal:  J Clin Med       Date:  2020-04-18       Impact factor: 4.241

8.  Correlation Between IVIM-DWI Parameters and Pathological Classification of Idiopathic Orbital Inflammatory Pseudotumors: A Preliminary Study.

Authors:  Jian Pu; Yi Liang; Qian He; Ju-Wei Shao; Min-Jie Zhou; Shu-Tian Xiang; Ying-Wen Li; Jian-Bo Li; Shun-Jun Ji
Journal:  Front Oncol       Date:  2022-03-11       Impact factor: 6.244

9.  Long-term Outcome in 7 Patients With Idiopathic Orbital Myositis.

Authors:  Toshihiko Matsuo
Journal:  Jpn Clin Med       Date:  2019-08-12
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.